Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Paired box protein Pax-7 (PAX7) is a transcription factor belonging to the paired box gene family, containing a paired domain, homeodomain, and octapeptide. It is essential for the regulation of muscle stem cell (satellite cell) proliferation and differentiation during myogenesis, as well as neural crest development. PAX7 maintains the stem cell state of satellite cells, preventing premature differentiation, and regulates the expression of critical myogenic genes such as ID2, ID3, and CXCR4. PAX7 is a biomarker for satellite cells and a rare subset of spermatogonial stem cells. Loss or mutation of PAX7 causes developmental defects, and oncogenic gene fusions such as PAX7-FOXO1 are strongly associated with alveolar rhabdomyosarcoma. No direct-acting drugs on PAX7 are currently known, but its expression and fusion partners serve as important diagnostic and prognostic markers in pediatric soft tissue cancers[1][2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Paired box protein Pax-7 (PAX7).